OptimizeRx Corporation

NASDAQ: OPRX · Real-Time Price · USD
17.14
-0.45 (-2.56%)
At close: Aug 15, 2025, 9:56 AM

OptimizeRx Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-20.11M -17.57M -11.44M 378.08K
Depreciation & Amortization
4.33M 2.4M 2.02M 2.09M
Stock-Based Compensation
11.47M 13.72M 15.75M 5.49M
Other Working Capital
3.16M -5.52M 1.12M 1.1M
Other Non-Cash Items
6.83M 9.76M 363.51K n/a
Deferred Income Tax
1.45M n/a n/a 80K
Change in Working Capital
921K -15.55M 3.96M -7.31M
Operating Cash Flow
4.89M -7.24M 10.65M 726.04K
Capital Expenditures
-112K -871.42K -244.56K -486K
Cash Acquisitions
n/a -80.4M -2M n/a
Purchase of Investments
n/a -162.78M -55.93M n/a
Sales Maturities Of Investments
n/a 218.71M n/a n/a
Other Investing Acitivies
-338K -784.02K n/a -385.68K
Investing Cash Flow
-450K -25.34M -58.18M -486K
Debt Repayment
-4M 36.02M n/a n/a
Common Stock Repurchased
-911K -7.8M -20.02M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 1.07M 3.25M
Financial Cash Flow
-4.91M 28.22M -18.95M 73.92M
Net Cash Flow
-472K -4.36M -66.47M 74.16M
Free Cash Flow
4.78M -8.11M 10.41M 240.04K